Ischemic stroke: Impact of a recent myocardial infarction

Stroke

Volumn 30, Issue 5, 1999, Pages 997-1001

  Mooe, Thomas ^a,b   Olofsson, Bert Ove ^a   Stegmayr, Birgitta ^a   Eriksson, Peter ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b Område Medicin   (Sweden)

Author keywords

Case control studies; Myocardial infarction; Stroke, ischemic

Indexed keywords

FIBRINOLYTIC AGENT;

ADULT; AGED; ARTICLE; BRAIN INFARCTION; BRAIN REGION; CARDIOVASCULAR RISK; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; CONSCIOUSNESS DISORDER; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE;

EID: 0032899809     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.30.5.997     Document Type: Article

References (26)

1. Hart RG. Cardiogenic embolism to the brain. Lancet. 1992;339:589-594.
2. Cardiogenic brain embolism: the second report of the Cerebral Embolism Task Force. Arch Neurol. 1989;46:727-743.
3. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet. 1991;337:1521-1526.
4. Lindgren A, Roijer A, Norrving B, Wallin L, Eskilsson J, Johansson BB. Carotid artery and heart disease in subtypes of cerebral infarction. Stroke. 1994;25:2356-2362.
5. Stegmayr B, Asplund K. Measuring stroke in the population: quality of routine statistics in comparison with a population-based stroke registry. Neuroepidemiology. 1992;11:204-213.
6. WHO MONICA Project Principle Investigators, prepared by Tunstall-Pedoe H. The World Health Organization MONICA Project (Monitoring of Trends and Determinants in Cardiovascular Disease): a major international collaboration. J Clin Epidemiol. 1988;41:105-114.
7. Stegmayr B, Asplund K. Exploring the declining case fatality in acute stroke: population-based observations in the Northern Sweden MONICA Project. J Intern Med. 1996;240:143-149.
8. Hess DC, D'Cruz IA, Adams RJ, Nichols FT. Coronary artery disease, myocardial infarction, and brain embolism. Neurol Clin. 1993;11: 399-417.
9. Gore JM, Granger CB, Simoons ML, Sloan MA, Weaver WD, White HD, Barbash GI, Van-de-Werf F, Aylward PE, Topol EJ. Stroke after thrombolysis: mortality and functional outcomes in the GUSTO-I trial: Global Use of Strategies to Open Occluded Coronary Arteries. Circulation. 1995;92:2811-2818.
10. Vaitkus PT, Barnathan ES. Embolic potential, prevention and management of mural thrombus complicating anterior myocardial infarction: a meta-analysis. J Am Coll Cardiol. 1993;22:1004-1009.
11. Bodenheimer MM, Sauer D, Shareef B, Brown MW, Fleiss JL, Moss AJ. Relation between myocardial infarct location and stroke. J Am Coll Cardiol. 1994;24:61-66.
12. Mooe T, Eriksson P, Stegmayr B. Ischemic stroke following acute myocardial infarction: a population-based study. Stroke. 1997;28:762-767.
13. Hellerstein HK, Martin JW. Incidence of thrombo-embolic lesions accompanying myocardial infarction. Am Heart J. 1947;33:443-452.
14. Miller RD, Jordan RA, Parker RL, Edwards JE. Thrombo-embolism in acute and in healed myocardial infarction, II: systemic and pulmonary arterial occlusion. Circulation. 1952;6:7-15.
15. Fulton RM, Duckett K. Plasma-fibrinogen and thromboemboli after myocardial infarction. Lancet. 1976;2:1161-1164.
16. Henny CP, Odoom JA, Cate H, Cate JW, Oosterhoff RJF, Dabhoiwala NF, Sih IL. Effects of extradural bupivacaine on the haemostatic system. Br J Anaesth. 1986;58:301-305.
17. Folts JD, Rowe GG. Epinephrine potentiation of in vivo stimuli reverses aspirin inhibition of platelet thrombus formation in stenosed canine coronary arteries. Thromb Res. 1988;50:507-516.
18. Loh E, St. John Sutton M, Chuan-Chuan CW, Rouleau JL, Flaker GC, Gottlieb SS, Lamas GA, Moye LA, Goldhaber SZ, Pfeffer MA. Ventricular dysfunction and the risk of stroke after myocardial infarction. N Engl J Med. 1997;336:251-257.
19. Easton JD, Sherman DG. Management of cerebral embolism of cardiac origin. Stroke. 1980;11:433-442.
20. Bean WB. Infarction of the heart, III: clinical course and morphological findings. Ann Intern Med. 1938;12:71-94.
21. Darling RC, Austen WG, Linton RR. Arterial embolism. Surg Gynecol Obstet. 1967;124:106-114.
22. Anderson CS, Taylor BV, Hankey GJ, Stewart-Wynne EG, Jamrozik KD. Validation of a clinical classification for subtypes of acute cerebral infarction. J Neurol Neurosurg Psychiatry. 1994;57:1173-1179.
23. Tanne D, Goldbourt U, Zion M, Reicher-Reiss H, Kaplinsky E, Behar S. Frequency and prognosis of stroke/TIA among 4808 survivors of acute myocardial infarction: the SPRINT Study Group. Stroke. 1993;24: 1490-1495.
24. Pullicino PM, Xuereb M, Aquilina J, Piedmonte MR. Stroke following acute myocardial infarction in diabetics. J Intern Med. 1992;231: 287-293.
25. Maggioni AP, Franzosi MG, Farina ML, Santoro E, Celani MG, Ricci S, Tognoni G. Cerebrovascular events after myocardial infarction: analysis of the GISSI trial: Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). BMJ. 1991;302:1428-1431.
26. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17 187 cases of suspected acute myocardial infarction: ISIS-2. Lancet. 1988;2:349-360.